PALO ALTO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced two new members of its Board of Directors. Brad Margus and Stephen Quake, D.Phil., join the Board to provide strategic guidance focused on ensuring operations have the greatest possible impact for generations to come. "With the addition of Brad and Stephen, our Board brings rich personal and professional experience in genetics, research, and nonprofit operations,” said ...

SUSTAINABILITY: This Mag 7 Member Targets AI Data Centers And All-Renewable ElectricityShares of Danaher (DHR) surged Tuesday, topping a buy zone, after the medical research company beat Wall Street's third-quarter forecasts on the back of its bioprocessing division.Revenue from the biotech division, which includes bioprocessing, grew 6.5% organically, topping guidance for 6% growth, Evercore ISI analyst Vijay Kumar said in a report. Bioprocessing is a key component to developing and manufacturing biologic ...

Partnership Overview - White Cap and DEWALT announce their third annual partnership to support St. Jude Children's Research Hospital, focusing on finding cures and saving children [1][5]. - The partnership includes a combined donation of $175,000 from DEWALT and White Cap, to be presented at the Charlotte Motor Speedway on October 5 [3][5]. Event Details - The 20 DEWALT car, driven by Christopher Bell, will feature art created by St. Jude patient Cameron, highlighting the collaboration between the patient and the Joe Gibbs Racing design team [2][4]. - DEWALT will contribute an additional $25,000 through the sale of select products at participating White Cap branches during October [3]. Company Contributions - White Cap's CEO, Alan Sollenberger, emphasizes the growth of the collaboration through donations and creative initiatives aimed at raising awareness and funding for St. Jude [5]. - DEWALT's President, Maria Ford, expresses pride in the partnership and the impact of showcasing patient art on the race car, reinforcing the commitment to support childhood cancer initiatives [5]. St. Jude Children's Research Hospital - St. Jude is recognized for its significant contributions to childhood cancer treatment, increasing the overall survival rate from 20% to over 80% since its inception [9]. - The hospital operates without charging families for treatment, allowing them to focus on their child's recovery [9].

Core Insights - The Lung Cancer Genetics Study, launched in 2024, aims to enroll 10,000 individuals diagnosed with lung cancer by 2027 and currently has over 1,200 participants, making it one of the most diverse cohorts for lung cancer genetics research [1][4] Group 1: Research Platform and Data Access - An open-source data platform has been launched for the Lung Cancer Genetics Study, allowing researchers to request access to de-identified data from consenting participants [2] - Approved researchers can access a unique lung cancer dataset at no cost through Lifebit's Trusted Research Environment (TRE), which includes germline genotyping and self-reported health data [3] - The platform is designed to eliminate data silos and enhance collaboration among researchers, enabling faster and more impactful discoveries [5][6] Group 2: Patient Engagement and Research Equity - The study emphasizes patient partnership, allowing participants to engage in the data governance process and influence future research [6] - The research environment is secure and compliant with standards such as DoD, NIST, GDPR, and HIPAA, ensuring sensitive data is protected [6] - The initiative aims to create a new model for research equity and access, addressing gaps in lung cancer research funding and participation [7][11] Group 3: Organizational Background - 23andMe Research Institute is a nonprofit organization focused on genetic research and aims to be a significant contributor to scientific advancement [9] - Lifebit is recognized as a leader in federated, secure, and AI-powered health data platforms, managing over 270 million patient records globally [10] - Troper Wojcicki Philanthropies (TWP) has dedicated 30% of its funding over the last 15 years to advancing cancer research, particularly lung cancer, in honor of Susan Wojcicki [11]

Group 1 - Medpace Holdings, Inc. (MEDP) has seen a 10.1% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - CB Financial Services, Inc. (CBFV) has experienced an 18.2% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Calix, Inc. (CALX) has recorded a 25.6% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - LendingTree, Inc. (TREE) has seen an 8.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Hasbro, Inc. (HAS) has experienced a 12.2% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3]

Company Overview - OpenEvidence 由 Daniel Nadler 创立，旨在帮助医生筛选大量医学研究 [1] - OpenEvidence 估值 35 亿美元，融资 2.1 亿美元 [1]

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation.FULL STORY: https://t.co/o3etlgkgUW(Photo: Mauricio Candela for Forbes) https://t.co/M96e5laeCh ...

Company Valuation & Funding - OpenEvidence's valuation reaches $3.5 billion [1] - OpenEvidence secures $210 million in funding [1] Business Focus - OpenEvidence assists physicians in navigating medical research [1] Founder - Daniel Nadler founded OpenEvidence [1]

Company Overview - Daniel Nadler founded OpenEvidence to assist physicians in navigating medical research [1] - OpenEvidence's valuation reaches $3.5 billion [1] - OpenEvidence secured $210 million in funding [1]

Company Overview - OpenEvidence was founded by Daniel Nadler to assist physicians in navigating medical research [1] - OpenEvidence has achieved a valuation of $35 billion [1] Funding - OpenEvidence has raised $210 million [1]